Leaps by Bayer
Leaps is the strategic impact investment unit of Bayer, founded in 2015. Has invested over $1 billion in ventures pursuing scientific breakthroughs in health (curing/preventing diseases) and agriculture (sustainable food production).
Leverkusen, Germany · 51+ investments · 39 portfolio companies
- Headquarters
- Leverkusen, Germany
- Founded
- 2015
- Website
- leaps.bayer.com
- AUM
- $2.1B
- Portfolio Companies
- 39
- Total Investments
- 51
- Last Investment
- Jul 2026
- Geographic Focus
- Global, United States, Europe, Germany, Worldwide
Indexed holds 39 portfolio companies and 51 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Leaps by Bayer is a Corporate VC firm based in Leverkusen, Germany. It has made 51 investments, including Gandeeva Therapeutics, ChrysaLabs and Celea Therapeutics. Focus areas include Agtech and Biotech.
Portfolio39
Co-investors24
Sign up to view co-investors
24 co-investors across 72 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×21 · Corporate VC ×2 · Hedge Fund ×1 · 75 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/leaps-by-bayer"><img src="https://indexed.vc/api/badge/investor/leaps-by-bayer" alt="Leaps by Bayer on Indexed.vc" width="260" height="76" /></a>